CF Patients Increase Bacterial Load But Lose Bacterial Diversity As They Age, Study Finds
Cystic fibrosis (CF) patients have more bacteria but lower bacterial diversity in their lungs than people without CF — yet bacterial...
Commission approves medical marijuana facilities
Stratford could eventually have two medical marijuana dispensaries in town, based on a Zoning Commission vote at the Nov. 14 meeting...
Case Report Provides New Insights on Dosing of Novel Drug for Patients with Cystic Fibrosis
Ceftolozane/tazobactam is safe, effective, and well-tolerated in the treatment of multidrug-resistant Pseudomonas aeruginosa infection...
Europe’s CHMP Gives Its Blessing to Vertex’s Orkambi as CF Therapy for Younger Children
The European Union’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for Orkambi...
Help Comes in the Form of Biosensors for Cystic Fibrosis Patients
A new biosensor tool’s been developed by Imperial researchers that lights up when any harmful bacteria is detected in the lung. ...
Vertex Doubles Scholarship Program to Support the Academic and Professional Advancement of People Li
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has doubled the number of scholarships for people living with cystic fibrosis (CF) and...
Mucociliary Clearence
Scott Donaldson, M.D., an associate professor of medicine and the director of the University of North Carolina adult CF center, provides...
#NACFC2017 – Latest Trial Data on Vertex CF Therapies and New Combos Show Benefits
Vertex Pharmaceuticals recently presented data from several clinical trials of cystic fibrosis treatments showing positive outcomes for...
